Latest News
Who doesn't want some extra passive income?
Via The Motley Fool · September 27, 2026
A 13.6% plunge in SpaceX tests investor risk, volatility, and earnings expectations.
Via The Motley Fool · September 27, 2026
AI could drive SpaceX's growth. It's also driving up costs.
Via The Motley Fool · September 27, 2026
Palisade Bio (NASDAQ:PALI) said it is advancing its lead drug candidate, PALI-2108, into Phase II studies for ulcerative colitis and Crohn’s disease after completing its Phase I program.
Chief Executive Officer JD Finley said PALI-2108 is a once-daily oral phosphodiesterase 4, or PDE4, inhibitor de
Via MarketBeat · September 27, 2026
The exuberance surrounding Intel's stock is getting a bit too high.
Via The Motley Fool · September 27, 2026
This biotech has grabbed plenty of headlines recently.
Via The Motley Fool · September 27, 2026
Lululemon's Leadership Just Got Called Out: What Governance Turmoil Could Mean for Investorsfool.com
Lululemon faces mounting governance risks as investors question leadership credibility.
Via The Motley Fool · September 27, 2026
One of the most challenging decisions to make as you near retirement is when to claim Social Security benefits. Here are five reasons 65 might be the sweet spot.
Via The Motley Fool · September 27, 2026
Should you buy at the high? The answer might surprise you.
Via The Motley Fool · September 27, 2026
SpaceX has some impressive business, but its stock has been anything but.
Via The Motley Fool · September 27, 2026
Strong leasing demand and limited new supply are boosting top-tier office REITs like SL Green, BXP and Hudson Pacific, which trade far cheaper than data-center REITs Equinix and Digital Realty.
Via MarketBeat · September 27, 2026
Investors can become their own worst enemies if their expectations aren't grounded in reality.
Via The Motley Fool · September 27, 2026
Xenon Pharmaceuticals (NASDAQ:XENE) said it has filed its first new drug application for azetukalner as a treatment for focal-onset seizures, while pausing portions of its late-stage psychiatry program to evaluate changes intended to improve tolerability.
Speaking at the 2026 TD Cowen Neuropsychiat
Via MarketBeat · September 27, 2026
Every year, NFL teams spend months studying the next class of potential stars. My colleague Louis Navellier sees a similar dynamic unfolding in the stock market today. After years of mega-cap dominance, smaller companies are beginning to take the lead—but that doesn’t mean every small-cap stock deserves a place in your portfolio.
Via InvestorPlace · September 27, 2026
Broadcom and Marvell are both gaining from the AI infrastructure boom, but one stock offers a better risk-reward proposition.
Via The Motley Fool · September 27, 2026
Green Thumb is profitable, cash-generative, and still reasonably valued.
Via The Motley Fool · September 27, 2026
Palo Alto Networks and Fortinet shares are up 112% and 125% this year, respectively, as AI-driven demand for cybersecurity fuels strong earnings and technical breakouts for both stocks.
Via MarketBeat · September 27, 2026
The demand for Intel's server CPUs is exceeding supply by a big margin.
Via The Motley Fool · September 27, 2026
This monthly dividend payer has raised its payout 136 times since 1994, and new data center and European deals could fuel further growth.
Via The Motley Fool · September 27, 2026
Dividend growth stocks have historically weathered market storms.
Via The Motley Fool · September 27, 2026
These high-yielding stocks offer very durable dividends.
Via The Motley Fool · September 27, 2026
Ford edges out GM in five of the last eight quarters, but the gap remains razor-thin—a pattern that could shift either way.
Via The Motley Fool · September 27, 2026
Meta is catching up with AI competitors, and investors are noticing.
Via The Motley Fool · September 27, 2026
Huron Consulting Group (NASDAQ:HURN) expects continued double-digit growth through 2029 as healthcare providers, higher-education institutions and commercial clients navigate financial pressure, technology modernization and regulatory complexity, Chief Financial Officer John Kelly said during the Si
Via MarketBeat · September 27, 2026
They are expected to go up again in October.
Via The Motley Fool · September 27, 2026